Page last updated: 2024-09-05

g(m1)-oligosaccharide and Lymphoma, Non-Hodgkin

g(m1)-oligosaccharide has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuerstacke, Y; Götze, KS; Meyer zum Büschenfelde, C; Peschel, C; Scholze, K1

Other Studies

1 other study(ies) available for g(m1)-oligosaccharide and Lymphoma, Non-Hodgkin

ArticleYear
GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.
    Cancer research, 2008, Jul-01, Volume: 68, Issue:13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Membrane Microdomains; Oligosaccharides; Prognosis; Rituximab

2008